BDBM50334494 4-((5-cyclohexyl-1-(4-(trifluoromethoxy)phenyl)-1H-pyrazol-4-yl)methyl)-N-(2H-tetrazol-5-yl)benzamide::CHEMBL1644176

SMILES FC(F)(F)Oc1ccc(cc1)-n1ncc(Cc2ccc(cc2)C(=O)Nc2nnn[nH]2)c1C1CCCCC1

InChI Key InChIKey=ATAZDKCXHQDNAJ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50334494   

TargetGlucagon receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50334494(4-((5-cyclohexyl-1-(4-(trifluoromethoxy)phenyl)-1H...)
Affinity DataIC50:  1.60E+4nMAssay Description:Displacement of [125I]glucagon from human GCGR expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastric inhibitory polypeptide receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50334494(4-((5-cyclohexyl-1-(4-(trifluoromethoxy)phenyl)-1H...)
Affinity DataIC50: >2.00E+4nMAssay Description:Antagonist activity at human GIPR expressed in CHO cells assessed as inhibition of glucagon-induced cAMP accumulationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed